{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"A Randomized Phase 3 Study of Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab, with or Without Platinum Chemotherapy, in Subjects with No Prior Therapy for Advanced or Metastatic PD-L1 TPS <50% Non-squamous Non-small Cell Lung Cancer Without Actionable Genomic Alterations  (Tropion-Lung07)","item":"https:\/\/www.regionalcancercare.org\/trials\/a-randomized-phase-3-study-of-datopotamab-deruxtecan-dato-dxd-and-pembrolizumab-with-or-without-platinum-chemotherapy-in-subjects-with-no-prior-therapy-for-advanced-or-metastatic-pd-l1-tps-2\/#breadcrumbitem"}]}